跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREGABALIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PREGABALIN
Authorized
STANDARD
PREGABALIN
altamed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6e1271645c125e33
Company
altamed pharma
Type
Standard
Approval Details
Approval Id
6e1271645c125e33
Drug Approval Canada Name
PREGABALIN
Product Name
PREGABALIN
Status
Marketed
Status Date
2018-08-22
Original Market Date
2018-08-22
Din
02474379
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N02BF02 PREGABALIN
Atc Name
n 02 bf 02
Aig Number
0151121003
Company Name
altamed pharma
Company Address
151 Boulevard De Mortagne, Boucherville, Quebec, Canada, J4B 6G4
Active Ingredients
PREGABALIN
75 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6e1271645c125e33
Type
Standard
Back to Health Canada Approvals